Related references
Note: Only part of the references are listed.Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase in Patients With Statin-Associated Autoimmune Myopathy
Andrew L. Mammen et al.
ARTHRITIS AND RHEUMATISM (2011)
Interferon-Stimulated Gene 15 (ISG15) Conjugates Proteins in Dermatomyositis Muscle with Perifascicular Atrophy
Mohammad Salaiegheh et al.
ANNALS OF NEUROLOGY (2010)
Dermatomyositis and polymyositis Clinical presentation, autoantibodies, and pathogenesis
Andrew L. Mammen
YEAR IN NEUROLOGY 2 (2010)
A Novel Autoantibody Recognizing 200-kd and 100-kd Proteins Is Associated With an Immune-Mediated Necrotizing Myopathy
Lisa Christopher-Stine et al.
ARTHRITIS AND RHEUMATISM (2010)
Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers
Conrad C. Weihl et al.
CURRENT OPINION IN NEUROLOGY (2010)
The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis
Cynthia M. Magro et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2010)
VASCULAR PATHOLOGY IN DERMATOMYOSITIS AND ANATOMIC RELATIONS TO MYOPATHOLOGY
Alan Pestronk et al.
MUSCLE & NERVE (2010)
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Kei Hoshino et al.
RHEUMATOLOGY (2010)
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis
Takahisa Gono et al.
RHEUMATOLOGY (2010)
Dermatomyositis and Type 1 Interferons
Steven A. Greenberg
Current Rheumatology Reports (2010)
Theories of the Pathogenesis of Inclusion Body Myositis
Steven A. Greenberg
Current Rheumatology Reports (2010)
Sporadic Inclusion Body Myositis: Pathogenic Considerations
George Karpati et al.
ANNALS OF NEUROLOGY (2009)
Magnetic Resonance Imaging of the Idiopathic Inflammatory Myopathies Structural and Clinical Aspects
Rodolfo Victor Curiel et al.
MRI AND ULTRASOUND IN DIAGNOSIS AND MANAGEMENT OF RHEUMATOLOGICAL DISEASES (2009)
Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis
Z. E. Betteridge et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Expression of the Dermatomyositis Autoantigen Mi-2 in Regenerating Muscle
Andrew L. Mammen et al.
ARTHRITIS AND RHEUMATISM (2009)
RNA Helicase Encoded by Melanoma Differentiation-Associated Gene 5 Is a Major Autoantigen in Patients With Clinically Amyopathic Dermatomyositis Association With Rapidly Progressive Interstitial Lung Disease
Shinji Sato et al.
ARTHRITIS AND RHEUMATISM (2009)
Autoantibodies to a 140-kd Protein in Juvenile Dermatomyositis Are Associated With Calcinosis
H. Gunawardena et al.
ARTHRITIS AND RHEUMATISM (2009)
Clinical Profile of Anti-PL-12 Autoantibody Cohort Study and Review of the Literature
Meena Kalluri et al.
CHEST (2009)
Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology
V. Madan et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond
Hector Chinoy et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
3-Hydroxy 3-Methylglutaryl Coenzyme A Reductase Increase Is Essential for Rat Muscle Differentiation
Chiara Martini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology
K. Nozaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies
Tetsuya Takada et al.
MODERN RHEUMATOLOGY (2009)
SARCOPLASMIC REDISTRIBUTION OF NUCLEAR TDP-43 IN INCLUSION BODY MYOSITIS
Mohammad Salajegheh et al.
MUSCLE & NERVE (2009)
Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5
Hua Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression
Harsha Gunawardena et al.
RHEUMATOLOGY (2009)
Immunoglobulin Gene Polymorphisms Are Susceptibility Factors in Clinical and Autoantibody Subgroups of the Idiopathic Inflammatory Myopathies
Terrance P. O'Hanlon et al.
ARTHRITIS AND RHEUMATISM (2008)
Vascular Endothelial Growth Factor Is Highly Expressed in Muscle Tissue of Patients With Polymyositis and Patients With Dermatomyositis
Cecilia Grundtman et al.
ARTHRITIS AND RHEUMATISM (2008)
Cytokine Gene Polymorphisms as Risk and Severity Factors for Juvenile Dermatomyositis
Gulnara Mamyrova et al.
ARTHRITIS AND RHEUMATISM (2008)
Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage
Xiomara Q. Rosales et al.
JOURNAL OF CHILD NEUROLOGY (2008)
Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus
Jennifer M. McNiff et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2008)
Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies
C. Sundaram et al.
NEUROLOGY INDIA (2008)
Mechanisms of Disease: autoantigens as clues to the pathogenesis of myositis
Tomeka L. Suber et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis
H. Gunawardena et al.
RHEUMATOLOGY (2008)
Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis
Ronan J. Walsh et al.
ARTHRITIS AND RHEUMATISM (2007)
Antagonistic interactions between lkaros and the chromatin remodeler Mi-2β determine silencer activity and Cd4 gene expression
Taku Naito et al.
IMMUNITY (2007)
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis
Hector Chinoy et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis
Zoe Betteridge et al.
ARTHRITIS AND RHEUMATISM (2007)
The role of MRI in the assessment of polymyositis and dermatomyrositis
J. Tomasova Studynkova et al.
RHEUMATOLOGY (2007)
Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia
Z. Betteridge et al.
RHEUMATOLOGY (2007)
The chromatin remodeler Mi-2β is required for establishment of the basal epidermis and normal differentiation of its progeny
Mariko Kashiwagi et al.
DEVELOPMENT (2007)
Progressive myopathy with up-regulation of MHC-I associated with statin therapy
Merrilee Needham et al.
NEUROMUSCULAR DISORDERS (2007)
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity
Emily C. Baechler et al.
MOLECULAR MEDICINE (2007)
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy
K. Kaji et al.
RHEUMATOLOGY (2007)
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy
G. J. D. Hengstman et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
A novel autoantibody to a 155-kd protein is associated with dermatomyositis
Ira N. Targoff et al.
ARTHRITIS AND RHEUMATISM (2006)
Cancer and myositis: new insights into an old association
Stuart M. Levine
CURRENT OPINION IN RHEUMATOLOGY (2006)
The heart in dermatomyositis and polymyositis
I. E. Lundberg
RHEUMATOLOGY (2006)
Sporadic inclusion body myositis - diagnosis, pathogenesis and therapeutic strategies
Marinos C. Dalakas
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies
P Mielnik et al.
AUTOIMMUNITY (2006)
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies - Distinct HLA-A -B, -Cw,-DRB1, and-DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies
TP O'Hanlon et al.
MEDICINE (2006)
Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen
GJD Hengstman et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Muscle symptoms associated with statins: A series of twenty patients
K Soininen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study
E Bruckert et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis
S Sato et al.
ARTHRITIS AND RHEUMATISM (2005)
Interferon-α/β-mediated innate immune mechanisms in dermatomyositis
SA Greenberg et al.
ANNALS OF NEUROLOGY (2005)
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
L Casciola-Rosen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Opioid use by patients in an orthopedics spine clinic
ML Mahowald et al.
ARTHRITIS AND RHEUMATISM (2005)
Polymyositis induced or associated with lipid-lowering drugs - Five cases
AL Fauchais et al.
REVUE DE MEDECINE INTERNE (2004)
Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis
M Fathi et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation
N Fujita et al.
CELL (2004)
Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects
L Dourmishev et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2004)
Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake
OM Vasconcelos et al.
MUSCLE & NERVE (2004)
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
DJ Graham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
The chromatin remodeler Mi-2β is required for CD4 expression and T cell development
CJ Williams et al.
IMMUNITY (2004)
Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy
AH Kao et al.
ARTHRITIS AND RHEUMATISM (2004)
Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies?
H Chinoy et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
Polymyositis and dermatomyositis
MC Dalakas et al.
LANCET (2003)
A comprehensive description of muscle symptoms associated with lipid-lowering drugs
S Franc et al.
CARDIOVASCULAR DRUGS AND THERAPY (2003)
Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies
IN Targoff
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2002)
Muscle biopsy findings in inflammatory myopathies
MC Dalakas
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2002)
Myopathy with antibodies to the signal recognition particle: clinical and pathological features
T Miller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Two-year efficacy and safety of Simvastatin 80 mg in familial hypercholesterolemia (The examination of probands and relatives in statin studies with familial hypercholesterolemia [ExPRESS FH])
PRWD Nolting et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians - Ethnogeographic influences in the genetics and clinical expression of myositis
EA Shamim et al.
ARTHRITIS AND RHEUMATISM (2002)
Inflammation in dysferlin myopathy:: Immunohistochemical characterization of 13 patients
E Gallardo et al.
NEUROLOGY (2001)
Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor
HB Wang et al.
NUCLEIC ACIDS RESEARCH (2001)
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
CL Hill et al.
LANCET (2001)
Share Paper
